Trials / Withdrawn
WithdrawnNCT02090517
Laser Therapy Versus Electrosurgery For Nasal Telangiectasias
Evaluation of Laser Therapy Vs Electrosurgery For Nasal Telangiectasias Using A Novel Vascular Imaging Device
- Status
- Withdrawn
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 0 (actual)
- Sponsor
- University of California, Davis · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The aim of this study is to compare the efficacy of various treatment options for eliminating nasal telangiectasias. The study will compare the outcome of treating nasal telangiectasias with the following; no treatment (control site), alexandrite laser, pulsed dye laser, combination pulsed dye laser and Nd:YAG 1064nm multiplex laser system and electrosurgery.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Pulsed Dye Laser | Pulsed dye laser treatments will be performed with a 595 nanometer wavelength, 20 millisecond pulse duration, at 10 Joules/cm2, with a 10 millimeter spot size. |
| DEVICE | Long Pulsed Alexandrite Laser | Alexandrite laser will be used with a 755 nanometer wavelength, 40 millisecond pulse duration, at 88Joules/cm2, with a 6 millimeter spot size. |
| DEVICE | Pulsed Dye Laser Plus Nd:YAG Laser | The Cynergy with MultiPlex will be used with a multiplex mode system with a pulse dye laser at 585 nanometer wavelength, 20 milliseconds pulse duration, at 7 Joules/cm2 with a 7 millimeter spot size, with a short delay, followed by a Nd:YAG 1064 nanometer wavelength, 20 millisecond pulse duration, at 50 Joules/cm2 with a 7 millimeter spot size. |
| PROCEDURE | Electrodesiccation | A curette is used to scrape off the cancer down to the dermis. The scraping is then paused while an electrosurgical device like a hyfrecator is used next. Electrodesiccation is performed over the raw surgical ulcer to denature a layer of the dermis and the curette is used again over the surgical ulcer to remove denatured dermis down to living tissue. |
Timeline
- Start date
- 2014-06-01
- Primary completion
- 2016-02-01
- Completion
- 2016-02-01
- First posted
- 2014-03-18
- Last updated
- 2017-06-29
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT02090517. Inclusion in this directory is not an endorsement.